News Pharma Industry

Government unveils National Policy on R&D in pharma, medtech


Union Health Minister Mansukh Mandaviya on Tuesday launched the National Policy on Research and Development and Innovation and introduced a scheme for the promotion of research and innovation to help transform the pharma and medtech sectors.

“Today is a historic day, an inflection point in the journey of “Atmanirbharta” in the pharma and medical devices sector. We need to transform Indian pharma & medtech sectors from a cost-based to a value-based and innovation-based industry,” the health minister said.

Enhance Your Healthcare Expertise with High-Impact Courses

Offering College Course Website
Indian School of Business ISB Healthcare Management Visit
IIM Kozhikode IIMK Healthcare Management & Analytics Programme Visit

The policy aims to encourage R&D in pharmaceuticals, including traditional medicines and phyto-pharmaceuticals along with medical devices. Mandaviya said that the scheme will focus on transforming India into a high-volume, high-value player in the global market of pharmaceuticals.

He said the policy will give impetus to new talent through startups by creating an ecosystem of skills and capacities including the academia and the private sectors. This is a transformative stage in the Indian drugs and med-tech sector, he stressed, where synergies are being created between various government institutions and agencies.


Source link